The choice of transcatheter heart valve (THV) platform, including self‐expanding valves (SEVs) and balloon‐expandable valves (BEVs), may influence outcomes in patients with peripheral artery disease (PAD) undergoing transfemoral transcatheter aortic… Click to show full abstract
The choice of transcatheter heart valve (THV) platform, including self‐expanding valves (SEVs) and balloon‐expandable valves (BEVs), may influence outcomes in patients with peripheral artery disease (PAD) undergoing transfemoral transcatheter aortic valve replacement (TAVR). This relationship remains underexplored in high‐risk populations with challenging vascular access.
               
Click one of the above tabs to view related content.